Literature DB >> 23730662

An interesting case of eosinophilic meningitis.

Shivanand Pai1, Deepak Madi, Basavaprabhu Achappa, Soundarya Mahalingam, Rakshith Kendambadi.   

Abstract

Angiostrongylus cantonensis is one of the causative agents of eosinophilic meningitis. Humans get infected when they ingest raw or partially cooked snails or monitor lizards (Varanus bengalensis). There is a popular belief that the tongue and the liver of the monitor lizard has aphrodisiac properties. A 20-year-old man was admitted to our hospital with a history of fever, headache and vomiting. His cerebrospinal fluid revealed eosinophilia. He gave a history of the ingestion of a monitor lizard, ten days prior to the onset of the symptoms. So, a diagnosis of eosinophilic meningitis due to Angiostrongylus cantonensis was made. He was treated with oral albendazole and prednisolone. His symptoms improved gradually within two weeks from his admission.

Entities:  

Keywords:  Angiostrongylus cantonensis; Eosinophilic meningitis; Monitor lizard

Year:  2013        PMID: 23730662      PMCID: PMC3644460          DOI: 10.7860/JCDR/2013/4743.2897

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Eosinophilic meningitis due to Angiostrongylus cantonensis.

Authors:  C Panackel; G Cherian; K Vijayakumar; R N Sharma
Journal:  Indian J Med Microbiol       Date:  2006-07       Impact factor: 0.985

Review 2.  Eosinophils in the cerebrospinal fluid.

Authors:  T Kuberski
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

Review 3.  Eosinophilic meningitis caused by Angiostrongylus cantonensis: report of 17 cases.

Authors:  H C Tsai; Y C Liu; C M Kunin; S S Lee; Y S Chen; H H Lin; T H Tsai; W R Lin; C K Huang; M Y Yen; C M Yen
Journal:  Am J Med       Date:  2001-08       Impact factor: 4.965

4.  Eosinophilic meningitis in Thailand. Clinical studies of 484 typical cases probably caused by Angiostrongylus cantonensis.

Authors:  S Punyagupta; P Juttijudata; T Bunnag
Journal:  Am J Trop Med Hyg       Date:  1975-11       Impact factor: 2.345

5.  Treatment of eosinophilic meningitis with a combination of albendazole and corticosteroid.

Authors:  Verajit Chotmongkol; Chatchawan Wongjitrat; Kookwan Sawadpanit; Kittisak Sawanyawisuth
Journal:  Southeast Asian J Trop Med Public Health       Date:  2004-03       Impact factor: 0.267

Review 6.  Update on eosinophilic meningoencephalitis and its clinical relevance.

Authors:  Carlos Graeff-Teixeira; Ana Cristina Arámburu da Silva; Kentaro Yoshimura
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

Review 7.  Eosinophilic meningitis.

Authors:  Vincent Lo Re; Stephen J Gluckman
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

8.  Occurrence of the infective stage of Angiostrongylus cantonensis in the yellow tree monitor (Varanus bengalensis) in five Provinces of Thailand.

Authors:  P Radomyos; A Tungtrongchitr; R Praewanich; P Khewwatchan; T Kantangkul; P Junlananto; S I Ayudhya
Journal:  Southeast Asian J Trop Med Public Health       Date:  1994-09       Impact factor: 0.267

  8 in total
  3 in total

1.  Eosinophilic Meningitis: Report of Three Cases from a Hilly Area in Kerala.

Authors:  Bindu Varghese; Murali Krishna Menon; Thara Pratap; A Moheen; Jomy Mathew; T P Vijayan; M P Tomy; Muhammed Jasim Abdul Jalal
Journal:  Ann Indian Acad Neurol       Date:  2019 Jan-Mar       Impact factor: 1.383

Review 2.  Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies.

Authors:  John Jacob; Argon Steel; Zhain Lin; Fiona Berger; Katrin Zöeller; Susan Jarvi
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 9.079

3.  A Curious Case of Eosinophilic Meningitis in a Family in Southern India.

Authors:  Poornima N Nambiar; T P Javed Ahamed; Sarika Sasidharan; Lovely Catherine Mathew; K A Salam
Journal:  Ann Indian Acad Neurol       Date:  2022-05-05       Impact factor: 1.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.